National Brain Tumor Society

My Dad was one of those people that everyone liked. People flocked to him for his humor, smile, and kindness.

NBTS CEO Discusses the current state of brain tumor recision medicine, as well as the challenges and opportunities that lay ahead

The author describes receiving a glioblastoma diagnosis at age 29 and navigating brain surgery, doctor visits, second opinions, support groups, and treatment decisions.

The company’s monthly glossary blogs covered CAR T-cell therapy and tumor sequencing, then asked whether a brain tumor is brain cancer.

Dr. Markus D. Siegelin received the 2013 AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research.

The National Brain Tumor Society hosted the inaugural Advancing Research to Therapies (ART) for Brain Tumors Conference in Washington, D.C., with more than 100 brain tumor researchers, biopharma executives, government officials, and venture capital investors.

National Brain Tumor Society announced the Defeat GBM Research Collaborative, an initiative that aims to double the five-year survival rate for patients with glioblastoma multiforme.

National Brain Tumor Society announced further details about the Defeat GBM Research Collaborative, which aims to double the five-year survival rate for patients with glioblastoma multiforme.

National Brain Tumor Society invests in and unites the brain tumor community to pursue a cure, deliver effective treatments, and advocate for patients and caregivers.

David Arons is the president and chief executive officer of the National Brain Tumor Society (NBTS) and provides leadership and management for NBTS and its venture philanthropy affiliate, the Brain Tumor Investment Fund.

The company invests in and unites the brain tumor community to pursue a cure, deliver effective treatments, and advocate for patients and caregivers.

The National Brain Tumor Foundation and the Brain Tumor Society, founded in the 1980s, merged in 2008 to form the National Brain Tumor Society (NBTS).

National Brain Tumor Society (NBTS) invests in and unites the brain tumor community and is committed to curing brain tumors and improving lives.

National Brain Tumor Society has funded more than $52 million in brain tumor research grants and awards to hundreds of researchers. Its advocacy efforts have helped improve public policies for patients.

The page lists headquarters at 55 Chapel Street, Suite 006, Newton, MA 02458, the phone number 617-924-9997, and social media accounts.

NBTS says every gift made through Sept. 30 will be matched dollar for dollar up to $50,000, thanks to Susan and Dan Ryan. September is Childhood Cancer Awareness Month.

The National Brain Tumor Society privacy policy, effective July 2021, describes how the organization collects and uses information.

The website’s information, services, and other materials are for educational and informational purposes and are not a substitute for medical advice and treatment.